Improved survival of patients with acute respiratory distress syndrome
Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Acute Respiratory Distress Syndrome
Therapeutics therapeutics market.
A review of the Acute Respiratory Distress Syndrome
products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Acute respiratory distress syndrome
describes a condition characterised by the acute onset of bilateral infiltrates on chest radiography, hypoxaemia (defined as a [P.
In addition, TLC C-53 is currently being tested in a Phase I/II clinical trial of Acute Respiratory Distress Syndrome
GlobalData's clinical trial report, Acute Respiratory Distress Syndrome
Global Clinical Trials Review, H2, 2011" provides data on the Acute Respiratory Distress Syndrome
clinical trial scenario.
Seven additional hospital admission categories were included in the surveillance system: hemoptysis, acute respiratory distress syndrome
or respiratory failure of uncertain origin, sepsis or nontraumatic shock, fever and rash, fever of unknown origin, gastrointestinal symptoms (vomiting, diarrhea, and dehydration), and skin infections.
The Company has filed applications to market ABLC(R) in Europe and is conducting Phase III of ABLC(R) studies for the treatment of systemic fungal infections in the US; TLC D-99 will be starting Phase III trials for the treatment of metastatic breast cancer; TLC C-53 is currently in Phase I/II trails for the treatment of Acute Respiratory Distress Syndrome
(ARDS) in the US and Phase I trials for Systemic Inflammatory Response Syndrome (SIRS) in Europe; TLC A-60 has entered Phase II trials as a liposomal adjuvant to be used in an influenza virus vaccine.
Global Markets Direct's, 'Acute Respiratory Distress Syndrome
- Pipeline Review, H2 2011', provides an overview of the Acute Respiratory Distress Syndrome
On day 13 of hospitalization, the patient's respiratory signs deteriorated markedly, with bilateral pulmonary infiltrates compatible with acute respiratory distress syndrome
The Company selectively develops proprietary parenteral pharmaceuticals for the treatment, prevention and diagnosis of inadequately treated, life- threatening diseases such as severe, systemic fungal infections, metastatic breast cancer, and inflammatory syndromes including acute respiratory distress syndrome
(ARDS) and systemic inflammatory response syndrome (SIRS).